Last Updated: Wednesday, January 16, 2013
Principal Investigator: Jeremy M. Veenstra-VanderWeele, M.D.
Other researchers: Cassandra Newsom, PhD Kevin Sanders, MD
Do you have a family member that has been diagnosed with Fragile X Syndrome?
We invite adults age 16– 50 for a study using an investigational drug. The purpose of the study is to try and find out if this medication is safe and helpful for patients with Fragile X syndrome. This is a randomized, double-blind, 12- week, parallel group, placebo controlled study of the efficacy and safety of RO4917523 in patients with Fragile X syndrome.
You will be asked to come for 7 visits to Vanderbilt University in Nashville, TN. to take part in this research study. A blood draw is required at 7 separate visits.
Adults age 16– 50 with Fragile X for a study using an investigational drug.
Evaluations, study visits, and study drug are provided at no cost. Compensation for transportation will be provided.
7 visits to Vanderbilt University in Nashville, TN.
Adults 18-45 with Fragile X syndromeCompensation: Yes
Adolescents (12-17 years old) with Fragile X syndromeCompensation: Yes
Adolescents and young adults (12-25 years old) with Fragile X syndromeCompensation: Yes
Children with a confirmed diagnosis of Fragile X between 3 and 11 years.Compensation: Yes
We are looking for children ages 6-12 with Autism, Asperger’s Syndrome, or PPD-NOS.Compensation: Yes
Visit this investigator's people page to list all of their studies together.